Saroja Pharma Approves FY26 Board Report and 8th AGM Notice
Saroja Pharma Industries India Ltd 路 Outcome 路 08 Sept 2026, 1:42 am
Saroja Pharma Approves FY26 Board Report and 8th AGM Notice Saroja Pharma Industries India Limited's Board of Directors met on 7th Sep'26 and approved the Draft Board's Report and Management Discussion & Analysis (MD&A) Report alongside their annexures for FY25-26, in compliance with the Companies Act, 2013, and SEBI (LODR) Regulations. Additionally, the board approved the draft notice convening the company's 8th Annual General Meeting (AGM) and finalized its scheduled date, time, and venue.
Original exchange filing (PDF)
More announcements from Saroja Pharma Industries India Ltd
- Saroja Pharma Industries India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Saroja Pharma Industries India Limited has informed the Exchange regarding Resignation of M/s Pravin Chandak & Associates, Chartered Accountants as Statutory Auditors of the company w.e.f. November 15, 2026. 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- Saroja Pharma Industries India Limited has informed the Exchange regarding Resignation of M/s Pravin Chandak & Associates, Chartered Accountants as Statutory Auditors of the company w.e.f. October 26, 2026. 路 26 Oct 2026
- Saroja Pharma Industries India Limited has informed the Exchange about Resignation of Director/KMP/SMP 路 06 Oct 2026
- Saroja Pharma Industries India Limited has informed the Exchange about Resignation of Director/KMP/SMP 路 06 Oct 2026
- Saroja Pharma Industries India Limited has informed the Exchange regarding Resignation of Mr. Ravindra Shivaji Salaskar as Whole-time Director of the company w.e.f. October 05, 2026. 路 05 Oct 2026
